Thyroid disorder decisions — 2022

The Veteran's claim for a compensable rating for hypothyroidism is denied as he does not have any residual symptoms or signs of the condition.

The Board has decided that the Veteran's claim for service connection for lung cancer cannot be readjudicated due to lack of new and relevant evidence. The issue of service connection for Hurthle cell carcinoma/thyroid cancer is remanded for further examination and opinion.

The Veteran's hypothyroidism was granted service connection on a presumptive basis for Agent Orange exposure. The effective date is set at September 29, 2016, and the disability evaluation is set at 10 percent.

The Veteran's claim for service connection for hypothyroidism was denied as there is no evidence of a chronic disease in service or within the presumptive period, and the Veteran did not have active service in Vietnam where herbicide exposure would be presumed.

The Veteran's hypothyroidism is presumed to be related to service in Vietnam. Service connection for lumbar and thoracic spine disabilities, obstructive sleep apnea, psoriasis, right lower extremity neuropathy, and left lower extremity neuropathy are remanded due to the need for additional medical examination.

The Board has granted service connection for hypertension and hypothyroidism, both of which are presumed to be related to the Veteran's exposure to herbicide agents during his military service.,No specific rating or effective date was assigned as the decision is solely about granting service connection.

The Board has remanded the claims for service connection for type 2 diabetes mellitus, chronic kidney disease, gout, glaucoma, liver disease, hernia, and thyroid disability due to in-service exposure at Camp Lejeune. The claims are pending as new and material evidence was submitted by the Appellant.

The Veteran's postoperative thyroid cancer residuals are rated at 30 percent, effective from August 1, 2007. The rating is based on the residual effects of hypothyroidism and iatrogenic hyperthyroidism.

The Veteran's hypothyroidism symptoms, including fatigue, constipation, and mental sluggishness, were found to be more nearly approximated by a rating of 30 percent from December 26, 2017, to July 20, 2021.

The Board has remanded the case due to inadequate compliance with previous remand directives and a need for a new examination by an endocrinologist.

The Veteran's stage IVA papillary thyroid cancer, with lymph node removal, is granted as service-connected due to presumed exposure to ionizing radiation during service.

Your claim for service connection for acute thyroiditis with hypothyroidism has been granted, and the appeal is dismissed.

The Veteran's hypothyroidism is presumed to be related to his in-service exposure to herbicide agents, and the Board has granted service connection for this condition.

The Board has determined that the Veteran does not have a current kidney disorder, and his claims for hyperthyroidism (Graves' Disease), eye disorder, GERD, right shoulder disability, bilateral hearing loss, and lumbar spine disability are remanded due to incomplete medical records and need further examination.

The Board has determined that new and relevant evidence has been received for both the claims of service connection for hypothyroidism and thyroid cancer, to include status post thyroid surgery. The cases are being remanded for further development including a VA examination.

The Board has vacated the July 2021 decision and remanded several issues related to service connection for various conditions.

The Veteran's claims for service connection for emphysema, erectile dysfunction, and chronic kidney disease are remanded due to the need for additional evidence. The other issues have been addressed with decisions granting or denying service connection.

The Veteran's service-connected disabilities did not render him unable to secure and follow a substantially gainful occupation prior to October 9, 2021. The Board found that the Veteran was still employed at the time of his appeal.

The Veteran's claim for a compensable rating prior to January 29, 2018, and in excess of 10 percent thereafter for hypogeusia is denied.,The Veteran's claim for a higher rating for his service-connected hypothyroidism is denied as the evidence does not support a higher 30-percent rating under either the previous or amended rating criteria for endocrine disorders.,The Veteran's claims for ratings in excess of 10 percent for peripheral neuropathy of the right and left lower extremities are denied.,TDIU claim since June 7, 2019 is dismissed as moot.

The Board has granted service connection for hypothyroidism and non-Hodgkin's lymphoma on a presumptive basis due to herbicide exposure in Thailand, as recognized by the PACT Act of 2022. Service connection is also granted for these conditions under direct evidence.